Navigation Links
Georgia State researcher gets $3.4 million grant to develop vaccine technology against flu, RSV
Date:1/30/2013

ATLANTA Sang-Moo Kang, associate professor at Georgia State University's Center for Inflammation, Immunity and Infection, has received a federal five-year, $3.4 million grant to bolster research that will lead to better flu vaccines and vaccines against respiratory syncytial virus (RSV), a disease for which there is no immunization.

The grant from the National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases will aid Kang's research in developing a virus-like particle, or VLP, vaccine technology.

VLPs mimic viruses, but are non-infectious, which allows for safer vaccines, especially for young children, elderly people and patients whose immune systems are compromised. VLPs trigger the immune system to respond, leading to immunity in the same way that regular vaccines made with whole viruses act.

"VLPs are a result of new technology using recombinant genetic engineering," Kang said. "VLP technology can manipulate pathogens in a safe way so that we can design a vaccine mimicking the shape and structure of a virus.

"A VLP is an empty particle without the genetic information of a pathogen, thus highlighting its safety."

The potential of this research could lead to not only better vaccines for influenza, which is potentially deadly in some patients and which has led to deaths during this year's flu season, but also RSV.

RSV is a respiratory virus that infects the lungs and breathing passages. Most healthy people can recover from RSV infection in one to two weeks, but infections can be severe in young children, infants and older adults.

According to the Centers for Disease Control and Prevention, about 75,000 to 125,000 hospitalizations related to RSV occur among children under one year old, and RSV infection results in about 1.5 million outpatient medical visits among children under the age of five.

Kang's lab will test VLP technology and ways to deliver the vac
'/>"/>

Contact: Jeremy Craig
404-413-1357
Georgia State University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Georgia Tech launches HomeLab to help companies evaluate home health technologies
2. Mary Rieser of Narconon Georgia Speaks Out For United Nations International Day Against Drug Abuse
3. NIH awards Georgia malaria research consortium up to $19.4 million contract
4. Georgia Partnership for TeleHealth, Inc. and Georgia's Lt. Governor Casey Cagle's Office Hosted the 2nd Annual School Based Health Center Summit on November 9, 2012
5. Piedmont Orthopaedic Complex is First to Provide Baseline Brain Function Test for Athletes in Central Georgia
6. Way to make one-way flu vaccine discovered by Georgia State researcher
7. Metro Atlanta ServiceMasters Team Up to Offer Higher Quality of Water Damage, Mold Removal, Carpet Cleaning and Fire Damage Services to Customers in North Georgia
8. Childcare Network Announces Acquisition of 22 Learning Centers from Children’s Friend of Georgia
9. Halcyon Completes First Acquisition in South Georgia
10. ShapeMed - http://www.ShapeMed.com - Offers Testosterone Screening for Men in Georgia
11. New target to stop cancers spread discovered by Georgia State scientists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... 18, 2014 Cristcot Inc., a ... and commercialization of specialized drug delivery systems, today ... Cristcot a patent for the technology, which encompasses ... , The patent was awarded to the ... have been assigned to Cristcot Inc. The patented ...
(Date:11/18/2014)... 18, 2014 Medicationdiscountcard.com's ... adding to the company's reputation for helping consumers ... blog has to offer at http://blog.medicationdiscountcard.com/ . ... information concerning the Affordable Care Act and the ... inform the public about a variety of prescription ...
(Date:11/18/2014)... Thompson HealthDay Reporter ... antibody drug could prove effective at lowering LDL ("bad") ... cholesterol-lowering statin medications. That,s the conclusion of a ... annual meeting in Chicago. The drug, alirocumab, outperformed ... used alternative to statins, Zetia, said lead researcher Dr. ...
(Date:11/18/2014)... (HealthDay News) -- Women who started smoking at a ... severe menstrual pain, a new study suggests. About ... smoking has been suspected as a risk factor for ... authors of the new study said. The researchers ... long-term study of women,s health in Australia. About 14 ...
(Date:11/18/2014)... November 18, 2014 Global ... using the telehealth platform to bring quality healthcare ... this passion, GPT created Global Partnership for TeleHealth ... already existing telehealth network. GPTM focuses specifically ... overseas, and disaster relief organizations. , ...
Breaking Medicine News(10 mins):Health News:Japanese Patent Office Grants Patent to Cristcot Inc. 2Health News:Medicationdiscountcard.com Building Virtual Library of Resources to Help Consumers Navigate Healthcare Landscape 2Health News:Experimental Cholesterol-Lowering Drug Effective, Study Reports 2Health News:Experimental Cholesterol-Lowering Drug Effective, Study Reports 3Health News:Study Ties Teen Smoking to Risk of Severe Menstrual Cramps 2Health News:Global Partnership for TeleHealth (GPT) is Focused on Using the telehealth Platform to Bring Quality Healthcare to Populations in Need Worldwide 2
... from Shropshire and parts of Wales. Breast cancer patients from ... but Welsh women get it for free. // ,This ... to pay for Herceptin for early stage breast cancer sufferers ... the welsh as all Welsh Local Health Boards have agreed ...
... in the capital of Zagreb it was revealed that a dead ... flu virus. //, ,The location of the dead swan was ... weekend. Tests confirmed that the dead bird had contracted the H5 ... it was the lethal H5N1 strain would be released on Sunday ...
... simulated investment game, a study, intending to investigate ... working //collectively in a team, revealed stark observations ... conducted by the University of Erfurt team, found ... when ‘punishments’ became a form of motivation. Psychologists ...
... nations should be prepared to pledge more money to combat ... ,Western and Asian donors had pledged $1.9 billion ... flu and improve containment and prevention methods in 12 countries, ... spreading across the world through migratory birds, including infections in ...
... should avoid exposure to the fumes of solvents used ... and lacquers//, could give rise to allergies in young ... Germany's environmental agency. ,Pregnant women should leave ... stay clear of the work area altogether. ...
... has warned the nation's betel-nut chewers of the increased ... habits like smoking and drinking. ,According to ... National Health Research Institute when betel nut chewing was ... cancer of the esophagus was about 195 times higher ...
Cached Medicine News:Health News:Free Herceptin Treatment for Those Who Live Over the Welsh Border 2Health News:Motivation Yardstick: Rewards or Punishment? Discover the Superior Performance Trigger 2Health News:Cancer Risks for Betel Nut Chewers 2
(Date:11/18/2014)... , Nov. 18, 2014  A new global ... finds that a large majority of the general public ... (84%), a devastating disease that is responsible for 1.59 ... cancers combined 1,2,4 . The "Any One Any Lung" ... about the widespread impact of lung cancer, but also ...
(Date:11/18/2014)... -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) ... receipt of approval from the U.S. Food and Drug ... IMPLANT ® Saline-filled Breast Implant for ... augmentation implants. The FDA approval of the IDEAL IMPLANT ... and data including a U.S. clinical trial that began ...
(Date:11/18/2014)... Tocagen Inc. today announced that ... free survival at six months for recurrent high grade ... FC, compared to published benchmarks. HGG includes glioblastoma, the ... The data were delivered in an oral presentation at the ... of the Society for Neuro-Oncology (SNO) by Tim ...
Breaking Medicine Technology:Global survey of more than 10,000 adults highlights misperceptions about lung cancer, a disease that kills 1.59 million people annually 2Global survey of more than 10,000 adults highlights misperceptions about lung cancer, a disease that kills 1.59 million people annually 3Global survey of more than 10,000 adults highlights misperceptions about lung cancer, a disease that kills 1.59 million people annually 4Global survey of more than 10,000 adults highlights misperceptions about lung cancer, a disease that kills 1.59 million people annually 5Global survey of more than 10,000 adults highlights misperceptions about lung cancer, a disease that kills 1.59 million people annually 6Valeant Pharmaceuticals And IDEAL IMPLANT Announce FDA And Health Canada Approval To Market Ideal Implant For Cosmetic Breast Augmentation 2Valeant Pharmaceuticals And IDEAL IMPLANT Announce FDA And Health Canada Approval To Market Ideal Implant For Cosmetic Breast Augmentation 3Interim Data Show Increased Median Overall Survival of Recurrent Brain Cancer Patients Treated with Tocagen's Toca 511 & Toca FC, Compared to Published Benchmarks 2Interim Data Show Increased Median Overall Survival of Recurrent Brain Cancer Patients Treated with Tocagen's Toca 511 & Toca FC, Compared to Published Benchmarks 3Interim Data Show Increased Median Overall Survival of Recurrent Brain Cancer Patients Treated with Tocagen's Toca 511 & Toca FC, Compared to Published Benchmarks 4Interim Data Show Increased Median Overall Survival of Recurrent Brain Cancer Patients Treated with Tocagen's Toca 511 & Toca FC, Compared to Published Benchmarks 5
... May 16 Pulmo BioTech Inc. (OTC,Bulletin Board: PLMO.OB) ... Phase I Human Trials with its PulmoBind Molecular Imaging,technology ... The work will be carried out by the Pulmo ... is: "Phase I Study of the Use,of PulmoBind for ...
... -- Results demonstrating that TYKERB and trastuzumab ... survival (PFS), -- Combining TYKERB and trastuzumab ... HER2 receptor may create a more complete HER2 ... alone despite patients,previous treatment with multiple lines of ...
Cached Medicine Technology:Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials 2Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials 3GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 2GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 3GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 4GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 5GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 6GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 7
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: